🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Published in Blood Cancer Journal “Some non-therapy-related key issues may represent a pre-requisite towards improving MM outcomes in the next few years.” nature.com/articles/s4140… IACH COMy Myeloma Patients Europe International Myeloma Foundation Multiple Myeloma Hub @MyelomaTeacher - Cindy Chmielewski Vincent Rajkumar Yelak Biru

📣Join us for the upcoming IACH Transplant Academy webinar Diagnosis and management of acute GVHD with Prof. Florent Malard 🗓️Monday, November 4, 2024 ⏲️6PM CET | 12PM NY Register for FREE ⬇️⬇️ bit.ly/4hBtuAv Mohamad Mohty

We are LIVE NOW! 🔽🔽🔽 bit.ly/3O3VTBF Transient Response with Elranatamab in a Case of Relapsed Refractory Multiple Myeloma with CNS Involvement FREE REGISTRATION! Meral Beksac Florent Malard Mohamad Mohty

IACH Florent Malard Mohamad Mohty I am proud to co-chair this junior club with F Malard and moderate the presentation by a very bright medical student from Istanbul on an extremely difficult functional high risk patient treated successfully with Elranatamab first to be published in CNS.

📍We are LIVE>> Diagnosis and Grading of Chronic GVHD 🔗Register for FREE bit.ly/4fJOZgC Steven Pavletic M.D., Ph.D. Mohamad Mohty Florent Malard

📍We are LIVE>> Blood Diseases in the ICU 🔗Register for FREE bit.ly/3YVOadC Elie Azoulay Mohamad Mohty Florent Malard

Another early morning at #ASH24 and it was great speaking with Florent Malard (Sorbonne Université) on novel microbiota-based therapies in transplantation: ⭐Pooled fecal allogenic microbiotherapy shows promise for refractory GI GvHD (European Early Access). ⭐Fecal microbiota

Modulation of the microbiota is the new frontier in hematology and cancer in general. #ASH24 IACH MaaT Pharma Mohamad Mohty

Despite efforts to understand, we still do not know how to use it. A survey-review of the current landscape of immune monitoring procedures in CAR-T cell therapies across EBMT-affiliated centers. 👇EBMT_Cellular_Therapy Annalisa Ruggeri Jurgen Kuball Christian Chabannon sciencedirect.com/science/articl…

🩸Managing steroid-resistant acute #GvHD 🩸Microbiome modulation in #transplantation 🩸The impact of antibiotic exposure before CAR-T on patients’ therapeutic outcomes These were the interesting topics we heard about from Florent Malard at #EBMT25 today! 🔜

Congratulations to the 2025 Jon J. van Rood Award winners Janaki Manoja Vinnakota (pictured) and Nicoletta Cieri! 👏 Read the recent interview as the winners speak on their individual, highly commended abstracts that were presented this morning at the EBMT_Cellular_Therapy Session at

📢Join us for the upcoming post #EBMT25 webinar in FRENCH Une table ronde de l'IACH focalisée sur les avancées en matière de GVHD en post-congres EBMT 🗓️April 9, 2025 ⏲️6pm CET FREE registration ⬇️⬇️ us06web.zoom.us/webinar/regist… Mohamad Mohty Florent Malard

We are LIVE! post #EBMT25 webinar in FRENCH: Une table ronde de l'IACH focalisée sur les avancées en matière de GVHD en post-congres EBMT FREE REGISTRATION us06web.zoom.us/webinar/regist… Mohamad Mohty Florent Malard

🎥 Watch our interview with Florent Malard from #EBMT25 last week to hear about the refinement of PTCy use to reduce side effects in patients receiving it for GvHD prophylaxis. Click here: 👉 ow.ly/sgUH50VxyZ0 #BMTsm #HemOnc The EBMT

Don’t miss this opportunity—save the date!📅 Scientific program, case submissions, and grants coming soon. Join us in beautiful Barcelona!🇪🇸 ebmt.org/events/10th-in…

Fantastic opportunity to be at the 14th annual SSBMT الخلاياالجذعية highlights of The EBMT and ASTCT in Dammam! Fantastic presentations today Anna Sureda Annalisa Ruggeri Florent Malard Nicola Polverelli, MD, PhD

Honored for the possibility of discussing about #CART for #autoimmunity at the SSBMT الخلاياالجذعية annual meeting in #Dammam! Fantastic second day with amazing presentations on cellular therapies ! Anna Sureda Nicola Polverelli, MD, PhD Annalisa Ruggeri Florent Malard raffaellagreco The EBMT

Congratulations for this very successful meeting!! Nicola Polverelli, MD, PhD Giorgio Orofino Florent Malard Annalisa Ruggeri

Practical discussions during ⁦COMy⁩ on how to manage patients with specific complications e.g. dialysis, extramedullary disease, etc. ⁦IACH⁩ ⁦Meral Beksac⁩ ⁦Rafat Abonour⁩ ⁦Florent Malard⁩

I am delighted to share that the impact factor of «Bone Marrow Transplantation» has risen to 5.2. THANK YOU to all our authors, editors, and reviewers for their great contributions and dedication to the journal’s continued success. Bipin Savani Springer Nature Florent Malard